114EGP
- Active ingredient
- vildagliptin
- Strength
- 50 mg
- Form
- tablet
- Manufacturer
- future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company
- Route
- oral.solid
Uses
Used to improve glycemic control in adults with type 2 diabetes mellitus.
Do not use if
Contraindicated in patients with hypersensitivity to vildagliptin or formulation components.
Side effects
Headache, dizziness, nausea, edema, and upper respiratory infections may occur.
Warnings
Monitor liver function and watch for symptoms of pancreatitis.
How it works
DPP-4 inhibitor that increases incretin hormone activity and improves glucose-dependent insulin secretion.
Storage
Store at room temperature.